MCRB — Seres Therapeutics Share News
0.000.00%
Last trade - 00:00- $20.78m
- $5.18m
- $0.79m
Seres Therapeutics Inc reports results for the quarter - Earnings Summary
Brief: Seres Therapeutics Reports Q3 2024 Financial Results And Provides Business Updates
Brief: Seres Therapeutics Q3 EPS USD 0.58
Seres Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
China's Zhongsheng hits nearly 12-month high; Jefferies lifts PT after Seres deal
Seres Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Chinese and European automakers face off at Paris car show (updated)
Chinese and European automakers face off at Paris car show
Brief: Seres Therapeutics Files Prospectus Related To Resale Of Up To 14.3 Million Shares Of Common Stock
Brief: Seres Therapeutics Stockholders Approve Sale of VOWST to Nestlé Health Science
Seres Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Seres Therapeutics Q2 EPS USD -0.22
Seres Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Seres Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ciena, Huntsman, Prog Holdings
U.S. STOCKS ON THE MOVE-Nvidia, Rubrik, Fly-E
U.S. STOCKS ON THE MOVE-Instacart, StoneCo, Brenmiller Energy
Seres falls after Nestle's health arm to acquire fecal transplant pill
Brief: Seres Therapeutics Enters Into MOU For VOWST Asset Sale To Nestlé Health Science